ORKA — Oruka Therapeutics

Median target
$155.5
calls from the last 12 months
Implied return
+56.2%
median target vs. price
Coverage
14 analysts · 17 calls
updated in the last 12 months
Consensus
14/0/0+14 net
Buy / Hold / Sell

Which analysts are behind ORKA's consensus?

See every current rating, price target and the analysts' track records for Oruka Therapeutics — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 14 analysts with calls on ORKA updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

ORKA elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)

DateSourceWhoActionDetailAmount
2026-11-02InsidersKlein Lawrence OttoChief Executive OfficerInsider sale15.0K sh @ $95.64 · planned trade$1.4M
2026-11-02InsidersKlein Lawrence OttoChief Executive OfficerInsider sale6.5K sh @ $94.77 · planned trade$613K
2026-11-02InsidersKlein Lawrence OttoChief Executive OfficerInsider sale2.4K sh @ $96.70 · planned trade$236K
2026-11-02InsidersKlein Lawrence OttoChief Executive OfficerInsider sale756 sh @ $97.45 · planned trade$74K
2026-11-02InsidersKlein Lawrence OttoChief Executive OfficerInsider sale300 sh @ $98.40 · planned trade$30K
2026-10-20InsidersQuinlan Paul TGeneral CounselInsider sale4.1K sh @ $78.79 · planned trade$323K
2026-10-20InsidersQuinlan Paul TGeneral CounselInsider sale3.0K sh @ $79.49 · planned trade$238K
2026-10-20InsidersQuinlan Paul TGeneral CounselInsider sale1.0K sh @ $77.20 · planned trade$77K
2026-10-20InsidersQuinlan Paul TGeneral CounselInsider sale500 sh @ $76.12 · planned trade$38K
2026-10-20InsidersQuinlan Paul TGeneral CounselInsider sale400 sh @ $74.90 · planned trade$30K

More: insider activity · executive branch · trending